Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CLK3 | P49761 | 17/20 | 0.73 |
| ▸ | DYRK1A | Q13627 | 17/20 | 0.73 |
| ▸ | CLK2 | P49760 | 16/20 | 0.73 |
| ▸ | AKT1 | P31749 | 1/20 | 0.50 |
| ▸ | WNT1 | P04628 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18446687 | 0.93 | CLK3 (0.63) | CLK3DYRK1ACLK2AKT1WNT1 | |
| SCHEMBL18485810 | 0.90 | CLK3 (0.62) | CLK3DYRK1ACLK2AKT1WNT1 | |
| SCHEMBL18447295 | 0.90 | CLK2 (0.59) | CLK3DYRK1ACLK2AKT1WNT1 | |
| SCHEMBL18444433 | 0.89 | CLK2 (0.58) | CLK3DYRK1ACLK2AKT1WNT1 | |
| SCHEMBL18447230 | 0.89 | DYRK1A (0.64) | CLK3DYRK1ACLK2 | |
| SCHEMBL18442064 | 0.89 | CLK2 (0.60) | CLK3DYRK1ACLK2AKT1WNT1 | |
| SCHEMBL18447322 | 0.88 | CLK3 (0.57) | CLK3DYRK1ACLK2WNT1 | |
| SCHEMBL18442398 | 0.87 | CLK2 (0.56) | CLK3DYRK1ACLK2AKT1WNT1 | |
| SCHEMBL18447352 | 0.87 | CLK3 (0.56) | CLK3DYRK1ACLK2WNT1 | |
| SCHEMBL18448446 | 0.86 | CLK3 (0.57) | CLK3DYRK1ACLK2WNT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017024013-A1 | 3-(1H-PYRROLO[2,3-C]PYRIDIN-2-YL)-1H-INDAZOLES AND THERAPEUTIC USES THEREOF | SAMUMED, LLC. (US) | 2017-02-09 | — | — | WO | claimed |